COVID-19: Are there clinical trial data to support a homologous vaccine booster?
This means those who have received Covishield as their first and second dose will receive Covishield as their third dose.
Read More
SARS-CoV-2
COVID-19: Even if mild, Omicron variant can overwhelming health-care settings
Huge percentage of the population in India got infected when the Delta variant raged through the country. Studies from other
Read More
COVID-19: India widens the vaccine safety net by immunising teenagers above 15 years
With all adults aged 18 years and above already being covered, the inclusion of teenagers has reduced the eligibility age
Read More
COVID-19: The basis on which India approved precaution dose remains unclear
He said the primary focus of the government was on giving a second dose of the vaccine to make people
Read More
COVID-19: India should prepare for the worst with Omicron
The World Health Organization said the number of COVID-19 cases recorded globally shot up by 11% last week (December 20-26)
Read More
Two COVID-19 antivirals get FDA nod for emergency use
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and
Read More
How the idea of COVID-19 vaccine protection changed in one year
On this day last year (December 11, 2020), Pfizer’s vaccine for COVID-19 was granted an emergency use authorisation, and exactly
Read More
Does the Omicron variant make a case for COVID-19 booster doses?
At a recent meeting, the National Technical Advisory Group on Immunisation maintained that it was not recommending a booster dose
Read More
Groping in the dark on COVID-19 booster doses
Even when clamour from a few States for booster doses increased once the new variant with higher transmissibility causing a
Read More
COVID-19: Mechanism of blood clots after Oxford vaccine administration found
Thrombosis with thrombocytopenia syndrome is a very rare serious adverse effects following vaccination using chimpanzee adenovirus Y25 (ChAdOx1), human adenovirus
Read More
Criticised if delayed in sharing COVID-19 data, punished for diligently posting data
After the first infection by a new variant — it has 32 mutations in the spike protein alone — was
Read More
Covaxin elicits immune memory to virus up to six months, study finds
The study has been posted on a preprint server medRxiv. Preprints are yet to be peer-reviewed and published in a
Read More
SARS-CoV-2 virus rages in Europe as epicentre shifts
The continent reported nearly two million new cases last week, the highest since the pandemic began, and more than half
Read More